• Publications
  • Influence
Effects of pentoxifylline on inflammatory parameters in chronic kidney disease patients: a randomized trial.
BACKGROUND Pentoxifylline (PTF) is a potential therapeutic agent in chronic kidney disease due to its antiinflammatory and antiproteinuric effects that may influence the progression of renal disease.Expand
Podocytes are new cellular targets of haemoglobin‐mediated renal damage
Recurrent and massive intravascular haemolysis induces proteinuria, glomerulosclerosis, and progressive impairment of renal function, suggesting podocyte injury. However, the effects of haemoglobinExpand
Remission of Hematuria Improves Renal Survival in IgA Nephropathy.
Hematuria is a cardinal symptom in IgA nephropathy, but its influence on the risk of disease progression has been scarcely investigated. We followed a cohort of 112 patients with IgA nephropathy forExpand
SARS-CoV-2 Infection in Hospitalized Patients With Kidney Disease
S ince the outbreak of coronavirus disease 2019 (COVID-19) in December 2019, the disease has spread rapidly across the globe. Up to April 1, 2020, there have been 823,626 confirmed cases and 40,598Expand
Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review
Haematuria has long been considered to be a benign condition associated with glomerular diseases. However, new evidences suggest that haematuria has a pathogenic role in promoting kidney diseaseExpand
CD163-Macrophages Are Involved in Rhabdomyolysis-Induced Kidney Injury and May Be Detected by MRI with Targeted Gold-Coated Iron Oxide Nanoparticles
Macrophages play an important role in rhabdomyolysis-acute kidney injury (AKI), although the molecular mechanisms involved in macrophage differentiation are poorly understood. We analyzed theExpand
Factors related with the progression of chronic kidney disease.
BACKGROUND Our aims were to determine the rate of progression of chronic kidney disease (CKD) and to identify predictors, with particular emphasis on bone and mineral metabolism. METHODSExpand
Management of resistant hypertension: Aldosterone antagonists or intensification of diuretic therapy?
No consensus has been established as to which is the best fourth‐line agent in patients with resistant hypertension (RHT). The aim of the present study was to assess the effect of intensifyingExpand
[Metabolic syndrome is associated with cardiovascular events in haemodialysis].
BACKGROUND Metabolic syndrome (MS) is a cardiovascular risk factor and is associated with mortality in the general population and in patients with chronic kidney disease. However, few studies haveExpand
Gastrointestinal complications induced by sevelamer crystals
Abstract Background Sevelamer is a phosphate binder widely used in chronic kidney disease (CKD) patients. Sevelamer, as well as other resin-based binders, can crystallize leading to the formation ofExpand